A Comparison Between Two Oral Hypoglycemics - Metformin and Glybenclamide for the Treatment of Gestational Diabetes Mellitus
Latest Information Update: 18 Sep 2021
Price :
$35 *
At a glance
- Drugs Glibenclamide (Primary) ; Metformin (Primary)
- Indications Gestational diabetes
- Focus Therapeutic Use
- 01 Nov 2016 Biomarkers information updated
- 28 Mar 2012 New trial record